![RemeGen Co., Ltd. logo](/logos/9995.HK.webp)
RemeGen Co., Ltd.
HKEX:9995.HK
Overview | Financials
Company Name | RemeGen Co., Ltd. |
Symbol | 9995.HK |
Currency | HKD |
Price | 12.46 |
Market Cap | 12,161,150,576 |
Dividend Yield | 0% |
52-week-range | 11.26 - 49 |
Industry | Biotechnology |
Sector | Healthcare |
CEO | Dr. Jianmin Fang |
Website | https://www.remegen.com |
An error occurred while fetching data.
About RemeGen Co., Ltd.
RemeGen Co., Ltd., a biopharmaceutical company, engages in the discovery, development, and commercialization of biologics for the treatment of autoimmune, oncology, and ophthalmic diseases with unmet medical needs in Mainland China and the United States. The company offers Telitacicept (RC18) for use in the treatment of systemic lupus erythematosus an
Related Stocks
Financials
Numbers are in millions USD
Numbers are in millions USD